Challenge: An emerging biopharma facing a PAI with an immature QMS
Startup and emerging life sciences companies often do not have a mature and complete quality management system in place for their commercialization activities. A strategic QMS framework reinforces a company's quality goals by implementing a governance structure and operational and procedural practices in support of product commercialization. This case study shares how USDM helped a pre-commercial company enhance and harmonize its QMS to prepare for an upcoming pre-approval inspection (PAI) and meet its regulatory compliance objectives.
The customer was an emerging biotechnology and pharmaceutical company with approximately 200 employees, in their pre-commercial, phase-3, late-stage clinical drug trials. They needed:
- Help identifying gaps and developing an implementation roadmap for their Quality Management System (QMS) — defining a deployment schedule and the new GxP capabilities to implement ahead of commercialization
- A high-performance team and professional project management to accelerate the timeline against a strict PAI deadline already scheduled with the regulatory authority
- Coordination and alignment across a large multi-functional team of stakeholders to support the new QMS implementation
- A cGMP training program to bring the organization up to speed on the latest regulatory requirements
With a fixed inspection date and gaps spanning policies, procedures, and data integrity practices, the customer could not afford a remediation effort that slipped.
Approach: A gap assessment and a remediation roadmap built to hold
USDM was selected because of the expertise of our consultants and our extensive life sciences domain experience. Our approach turned an open-ended compliance problem into a scheduled, accountable program of work.
- USDM performed a gap assessment of the customer's existing QMS
- We created and implemented a strategic roadmap to remediate the QMS gaps identified
- USDM's senior program manager built a detailed timeline to ensure remediation was delivered ahead of schedule and without delays
- We conducted the remediation and facilitated communication and collaboration between all stakeholders to gain alignment and complete the required deliverables
- USDM drafted 50+ SOPs and integrated the new policies and procedures within the customer's existing QMS
- We developed and delivered a cGMP training curriculum program enabling the customer to educate its teams and achieve their quality requirements
Built for inspection readiness
Because the work was scoped against a hard PAI date, every deliverable was sequenced to the inspection timeline. Establishing a defensible procedural baseline this way is the same foundation that supports a continuous compliance posture and modern, risk-based validation under Computer Software Assurance (CSA) as the organization scales toward commercialization.
Results
USDM delivered the harmonized QMS the customer needed to face its regulator with confidence — on time and complete.
- Less than 6 months to remediate the customer's QMS
- 50+ new SOPs delivered and integrated into the existing QMS
- PAI deadline achieved to meet regulatory requirements
By pairing senior program management with deep GxP expertise, USDM converted an immature quality system and a fixed inspection deadline into a commercialization-ready QMS — delivered ahead of schedule, fully aligned across stakeholders, and supported by a trained organization. Learn more about USDM's commercialization QMS framework.